These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2113224)

  • 1. The effect of peritonitis on the transperitoneal transport of cefuroxime in patients on CAPD treatment.
    Dahl K; Walstad RA; Widerøe TE
    Nephrol Dial Transplant; 1990; 5(4):275-81. PubMed ID: 2113224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of single daily intraperitoneal administration of aztreonam and cefuroxime in the treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD).
    Fuiano G; Sepe V; Viscione M; Nani E; Conte G
    Perit Dial Int; 1989; 9(4):273-5. PubMed ID: 2488380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral treatment of peritonitis complicating continuous ambulatory peritoneal dialysis.
    Searle M; Raman GV
    Clin Nephrol; 1985 May; 23(5):241-4. PubMed ID: 4006333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of peritonitis on the distribution of cefuroxime in patients undergoing continuous ambulatory peritoneal dialysis.
    McIntosh ME; Smith WG; Junor BJ; Forrest G; Brodie MJ
    Scott Med J; 1984 Apr; 29(2):117-8. PubMed ID: 6531683
    [No Abstract]   [Full Text] [Related]  

  • 5. Cefuroxime pharmacokinetics in continuous and intermittent peritoneal dialysis.
    Chan MK; Browning AK; Poole CJ; Matheson LA; Li CS; Baillod RA; Moorhead JF
    Nephron; 1985; 41(2):161-5. PubMed ID: 4047273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin pharmacokinetics in continuous ambulatory peritoneal dialysis patients with peritonitis.
    Harford AM; Sica DA; Tartaglione T; Polk RE; Dalton HP; Poynor W
    Nephron; 1986; 43(3):217-22. PubMed ID: 3724930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intermittent intraperitoneal ceftazidime.
    Grabe DW; Bailie GR; Eisele G; Frye RF
    Am J Kidney Dis; 1999 Jan; 33(1):111-7. PubMed ID: 9915275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
    Manley HJ; Bailie GR; Asher RD; Eisele G; Frye RF
    Perit Dial Int; 1999; 19(1):65-70. PubMed ID: 10201343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nikolaidis P; Walker SE; Dombros N; Tourkantonis A; Paton TW; Oreopoulos DG
    Perit Dial Int; 1991; 11(1):59-63. PubMed ID: 2049424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased peritoneal permeability in patients with peritonitis undergoing continuous ambulatory peritoneal dialysis.
    McIntosh ME; Smith WG; Junor BJ; Forrest G; Brodie MJ
    Eur J Clin Pharmacol; 1985; 28(2):187-91. PubMed ID: 3987798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of single dose intravenous vancomycin in CAPD peritonitis.
    Whitby M; Edwards R; Aston E; Finch RG
    J Antimicrob Chemother; 1987 Mar; 19(3):351-7. PubMed ID: 3571051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
    Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transperitoneal movement and pharmacokinetics of cefotiam and cefsulodin in patients on continuous ambulatory peritoneal dialysis.
    Brouard R; Tozer TN; Merdjan H; Guillemin A; Baumelou A
    Clin Nephrol; 1988 Oct; 30(4):197-206. PubMed ID: 3214965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of teicoplanin in patients undergoing continuous ambulatory peritoneal dialysis.
    Stamatiadis D; Papaioannou MG; Giamarellos-Bourboulis EJ; Marinaki S; Giamarellou H; Stathakis CP
    Perit Dial Int; 2003; 23(2):127-31. PubMed ID: 12713078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritonitis complicating continuous ambulatory peritoneal dialysis in Nottingham 1983-1988.
    Wilcox MH; Finch RG; Burden RP; Morgan AG
    J Med Microbiol; 1991 Mar; 34(3):137-41. PubMed ID: 2010903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.
    Lui SL; Cheng SW; Ng F; Ng SY; Wan KM; Yip T; Tse KC; Lam MF; Lai KN; Lo WK
    Kidney Int; 2005 Nov; 68(5):2375-80. PubMed ID: 16221243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
    Low CL; Gopalakrishna K; Lye WC
    J Am Soc Nephrol; 2000 Jun; 11(6):1117-1121. PubMed ID: 10820176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term changes in transperitoneal water transport during continuous ambulatory peritoneal dialysis.
    Wideröe TE; Smeby LC; Mjåland S; Dahl K; Berg KJ; Wessel Aas T
    Nephron; 1984; 38(4):238-47. PubMed ID: 6514073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
    Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.